ENTITY
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY US)

88
Analysis
Health Care • United States
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
more
Exchange Announcement • 30 Jul 2026 20:11

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 30 Jul 2026 20:06

Current Report (Form 8-K | Period ending 2026-07-30)

Exchange Announcement • 28 May 2026 04:30

Current Report (Form 8-K | Period ending 2026-05-20)

Exchange Announcement • 30 Apr 2026 20:16

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

Exchange Announcement • 30 Apr 2026 20:04

Current Report (Form 8-K | Period ending 2026-04-30)

x